Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles
Open Access
- 1 September 2000
- journal article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 44 (3), 433-439
- https://doi.org/10.1002/1522-2594(200009)44:3<433::aid-mrm14>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide.European Journal of Nuclear Medicine and Molecular Imaging, 1998
- Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imagingNature Medicine, 1998
- Angiogenesis and Tumor MetastasisAnnual Review of Medicine, 1998
- Assessing tumor angiogenesis using macromolecular MR imaging contrast mediaJournal of Magnetic Resonance Imaging, 1997
- Expression of Integrin ανβ3 in Small Blood Vessels of Glioblastoma TumorsJournal of Neuropathology and Experimental Neurology, 1996
- Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.Radiology, 1996
- Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.JCI Insight, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Expression of β1, β3, β4, and β5 Integrins by Human Lung Carcinoma Cells of Different HistotypesExperimental Cell Research, 1994
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990